These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 19500161)
21. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy. Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559 [TBL] [Abstract][Full Text] [Related]
22. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Schmittdiel JA; Nichols GA; Dyer W; Steiner JF; Karter AJ; Raebel MA Med Care; 2015 Apr; 53(4):332-7. PubMed ID: 25719517 [TBL] [Abstract][Full Text] [Related]
23. Pharmacy effect on adherence to antidiabetic medications. Sharma KP; Taylor TN Med Care; 2012 Aug; 50(8):685-91. PubMed ID: 22354211 [TBL] [Abstract][Full Text] [Related]
24. Use of Pharmacy Sales Data to Assess Changes in Prescription- and Payment-Related Factors that Promote Adherence to Medications Commonly Used to Treat Hypertension, 2009 and 2014. Ritchey M; Tsipas S; Loustalot F; Wozniak G PLoS One; 2016; 11(7):e0159366. PubMed ID: 27428008 [TBL] [Abstract][Full Text] [Related]
25. Financial Strain and Medication Adherence among Diabetes Patients in an Integrated Health Care Delivery System: The Diabetes Study of Northern California (DISTANCE). Lyles CR; Seligman HK; Parker MM; Moffet HH; Adler N; Schillinger D; Piette JD; Karter AJ Health Serv Res; 2016 Apr; 51(2):610-24. PubMed ID: 26256117 [TBL] [Abstract][Full Text] [Related]
26. Association Between Cost-Saving Prescription Policy Changes and Adherence to Chronic Disease Medications: an Observational Study. Haff N; Sequist TD; Gibson TB; Benevent R; Sears ES; Chaguturu S; Lauffenburger JC J Gen Intern Med; 2022 Feb; 37(3):531-538. PubMed ID: 34331213 [TBL] [Abstract][Full Text] [Related]
27. What can primary care prescribing data tell us about individual adherence to long-term medication?-comparison to pharmacy dispensing data. Mabotuwana T; Warren J; Harrison J; Kenealy T Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):956-64. PubMed ID: 19609958 [TBL] [Abstract][Full Text] [Related]
28. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Raebel MA; Schmittdiel J; Karter AJ; Konieczny JL; Steiner JF Med Care; 2013 Aug; 51(8 Suppl 3):S11-21. PubMed ID: 23774515 [TBL] [Abstract][Full Text] [Related]
29. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Grant RW; Singer DE; Meigs JB Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984 [TBL] [Abstract][Full Text] [Related]
31. Statin Adherence Rates in Patients Utilizing a Patient-Centered Medical Home-Based Pharmacy. Slazak EM; Kozakiewicz JT; Winters NS; Smith JR; Monte SV J Pharm Pract; 2017 Oct; 30(5):516-520. PubMed ID: 27599748 [TBL] [Abstract][Full Text] [Related]
32. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs. Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811 [TBL] [Abstract][Full Text] [Related]
33. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia. Doshi JA; Li P; Desai S; Marcus SC J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299 [TBL] [Abstract][Full Text] [Related]
34. Association Between Pharmacy Closures and Adherence to Cardiovascular Medications Among Older US Adults. Qato DM; Alexander GC; Chakraborty A; Guadamuz JS; Jackson JW JAMA Netw Open; 2019 Apr; 2(4):e192606. PubMed ID: 31002324 [TBL] [Abstract][Full Text] [Related]
35. Effect of a medication copayment increase in veterans with schizophrenia. Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234 [TBL] [Abstract][Full Text] [Related]
36. Measuring concurrent adherence to multiple related medications. Choudhry NK; Shrank WH; Levin RL; Lee JL; Jan SA; Brookhart MA; Solomon DH Am J Manag Care; 2009 Jul; 15(7):457-64. PubMed ID: 19589013 [TBL] [Abstract][Full Text] [Related]
37. Overactive bladder medication adherence when medication is free to patients. Sears CL; Lewis C; Noel K; Albright TS; Fischer JR J Urol; 2010 Mar; 183(3):1077-81. PubMed ID: 20092838 [TBL] [Abstract][Full Text] [Related]
38. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457 [TBL] [Abstract][Full Text] [Related]
39. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy. Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182 [TBL] [Abstract][Full Text] [Related]
40. Impact of medication synchronization programs on proportion of days covered (PDC) scores and Medicare Part D medication-related adherence metrics. Bernard K; Cowles B; McCall K; Henningsen RM; O'Toole M; Tu C J Am Pharm Assoc (2003); 2019; 59(3):343-348. PubMed ID: 30940515 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]